drugset / Trial / NCT01935908

Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study

NCT01935908

RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to determine the feasibility of prospectively enrolling and randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam or not to receive levetiracetam, and documenting in-hospital and follow-up clinical variables.

Timeline

Start
2013-05
Primary completion
2013-05
Completion
2013-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 500 mg Oral